Becton Dickinson BDX
NYSE BDX
$179.76 +1.71 (+0.96%)
As of: Sep 9, 2026 · 3:59 PM EDT

Becton Dickinson (BDX) Restructuring Costs (2015 - 2026)

Becton Dickinson's (BDX) quarterly Restructuring Costs came in at $89.0 million in Q2 2026, down 7.29% year-over-year from $96.0 million in Q2 2025, and down 83.3% quarter-over-quarter from $533.0 million in Q1 2026.

Analysis

Becton Dickinson (BDX) Restructuring Costs (2015 - 2026) Analysis & Trends

Becton Dickinson (BDX) has reported Restructuring Costs for 12 consecutive years, with $89.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Restructuring Costs fell 7.29% year-over-year to $89.0 million in Q2 2026; TTM through Jun 2026 was $864.0 million, a 91.57% increase from a year earlier, with the FY2025 full-year figure at $408.0 million, down 10.92% from the prior year.
  • Restructuring Costs was $89.0 million for Q2 2026 at Becton Dickinson, down from $533.0 million in the prior quarter.
  • Over five years, Restructuring Costs peaked at $533.0 million in Q1 2026 and troughed at $28.0 million in Q1 2022.
  • A 5-year average of $115.2 million and a median of $92.5 million in 2024 frame the typical range for Restructuring Costs.
  • Across the five-year window, Restructuring Costs tumbled 46.15% in 2022 and jumped 473.12% in 2026, its largest moves.
  • Over 5 years, Restructuring Costs stood at $44.0 million in 2022, then soared by 70.45% to $75.0 million in 2023, then rose by 22.67% to $92.0 million in 2024, then grew by 20.65% to $111.0 million in 2025, then retreated by 19.82% to $89.0 million in 2026.
  • The last three Restructuring Costs figures came in at $89.0 million (Q2 2026), $533.0 million (Q1 2026), and $111.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Becton Dickinson 49.48 Bn 48.62 Bn 2.32 Bn
2 Medline 29.24 Bn 26.56 Bn 2.22 Bn
3 West Pharmaceutical Services 23.94 Bn 23.51 Bn 329.20 Mn
4 Baxter International 12.66 Bn 10.51 Bn 1.03 Bn
5 Stevanato Group S.p.A 5.51 Bn 5.40 Bn 100.91 Mn
6 Acme United 233.67 Mn 228.63 Mn 26.69 Mn
7 Rockwell Medical 31.87 Mn 7.07 Mn 3.24 Mn
8 Retractable Technologies 21.39 Mn -18.48 Mn 190,852.00
9 United Health Products 9.09 Mn 9.06 Mn -
10 Cuprina Holdings (Cayman) 7.45 Mn 4.33 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 89.00 Mn
Mar 31, 2026 533.00 Mn
Dec 31, 2025 111.00 Mn
Sep 30, 2025 131.00 Mn
Jun 30, 2025 96.00 Mn
Mar 31, 2025 93.00 Mn
Dec 31, 2024 92.00 Mn
Sep 30, 2024 170.00 Mn
Jun 30, 2024 112.00 Mn
Mar 31, 2024 101.00 Mn
Dec 31, 2023 75.00 Mn
Sep 30, 2023 138.00 Mn
Jun 30, 2023 70.00 Mn
Mar 31, 2023 62.00 Mn
Dec 31, 2022 44.00 Mn
Sep 30, 2022 74.00 Mn
Jun 30, 2022 55.00 Mn
Mar 31, 2022 28.00 Mn
Dec 31, 2021 34.00 Mn
Sep 30, 2021 58.00 Mn